Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

[1]  Y. Qi,et al.  BMI levels with MS Bone mineral density levels in adults with multiple sclerosis: a meta-analysis , 2015, The International journal of neuroscience.

[2]  C. Wolfson,et al.  Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review , 2015, European journal of neurology.

[3]  S. Bi,et al.  Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis , 2014, Neuroscience Letters.

[4]  J. Ioannidis,et al.  Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials , 2014, BMJ : British Medical Journal.

[5]  T. Psaltopoulou,et al.  Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case–control studies , 2014, Therapeutic advances in neurological disorders.

[6]  Eduardo L. Franco,et al.  Making Prospective Registration of Observational Research a Reality , 2014, Science Translational Medicine.

[7]  T. Olsson,et al.  Cytomegalovirus seropositivity is negatively associated with multiple sclerosis , 2014, Multiple sclerosis.

[8]  Shawn N. Fraser,et al.  Physical trauma and risk of multiple sclerosis: A systematic review and meta-analysis of observational studies , 2014, Journal of the Neurological Sciences.

[9]  V. Johnson.  Revised standards for statistical evidence , 2013, Proceedings of the National Academy of Sciences.

[10]  J. Ioannidis.  Clarifications on the application and interpretation of the test for excess significance and its extensions , 2013 .

[11]  C. Wolfson,et al.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review , 2013, BMC Neurology.

[12]  D. Davenport,et al.  Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis , 2013, Vascular and endovascular surgery.

[13]  J. Ioannidis,et al.  Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases , 2013, PLoS biology.

[14]  Shawn N. Fraser,et al.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case–control studies , 2013, BMC Neurology.

[15]  J. Ioannidis,et al.  Bias in associations of emerging biomarkers with cardiovascular disease. , 2013, JAMA internal medicine.

[16]  A. Avenell,et al.  Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis , 2013, PloS one.

[17]  L. Carroll,et al.  Traumatic Injury and Multiple Sclerosis: A Systematic Review and Meta-Analysis , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[18]  G. Giovannoni,et al.  The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis , 2013, Multiple sclerosis.

[19]  Christina Wolfson,et al.  Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review , 2013, Neuroepidemiology.

[20]  S. Weiss,et al.  Prolactin in multiple sclerosis , 2013, Multiple sclerosis.

[21]  A. Figueiras,et al.  Central nervous system demyelinating diseases and recombinant hepatitis B vaccination: a critical systematic review of scientific production , 2013, Journal of Neurology.

[22]  J. Ioannidis,et al.  Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. , 2012, Journal of the National Cancer Institute.

[23]  C. A. Speck-Hernandez,et al.  Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis , 2012, PloS one.

[24]  J. Lünemann,et al.  The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.

[25]  L. Tesio,et al.  Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial , 2012, Trials.

[26]  J. Ioannidis.  The importance of potential studies that have not existed and registration of observational data sets. , 2012, JAMA.

[27]  J. Ioannidis,et al.  Corrigendum to "STrengthening the Reporting of OBservational studies in Epidemiology — Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement" (Prev. Med. 53 (2011) 377-387) , 2012 .

[28]  Kaiwen Xiao,et al.  Serum uric acid levels in patients with multiple sclerosis: a meta-analysis , 2012, Neurological research.

[29]  A. Laupacis,et al.  Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis , 2011, Canadian Medical Association Journal.

[30]  John P A Ioannidis,et al.  Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study , 2011, BMJ : British Medical Journal.

[31]  H. Varmus,et al.  Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention , 2011, Science Translational Medicine.

[32]  J. Ioannidis,et al.  STrengthening the reporting of OBservational studies in Epidemiology—Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement , 2011, European Journal of Epidemiology.

[33]  J. Ioannidis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement , 2011, PLoS medicine.

[34]  J. Ioannidis,et al.  Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.

[35]  Zhi-yi He,et al.  Meta-analysis of the relationship between homocysteine, vitamin B12, folate, and multiple sclerosis , 2011, Journal of Clinical Neuroscience.

[36]  J. Ioannidis,et al.  The False-positive to False-negative Ratio in Epidemiologic Studies , 2011, Epidemiology.

[37]  J. Stankovich,et al.  Individual and joint action of environmental factors and risk of MS. , 2011, Neurologic clinics.

[38]  L. Blizzard,et al.  Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  J. Correale,et al.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis , 2011, Journal of Neurology.

[40]  E. Alexopoulos,et al.  Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review , 2011, Neuroepidemiology.

[41]  G. Giovannoni,et al.  Smoking and Multiple Sclerosis: An Updated Meta-Analysis , 2011, PloS one.

[42]  A. Souza-Machado,et al.  Association between allergies and multiple sclerosis: a systematic review and meta‐analysis , 2011, Acta neurologica Scandinavica.

[43]  Hongyu Zhou,et al.  Rituximab for relapsing-remitting multiple sclerosis. , 2011, The Cochrane database of systematic reviews.

[44]  G. Giovannoni,et al.  An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis , 2010, PloS one.

[45]  G. Giovannoni,et al.  Multiple sclerosis: risk factors, prodromes, and potential causal pathways , 2010, The Lancet Neurology.

[46]  J. Gutiérrez,et al.  Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[47]  J. Lünemann,et al.  Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis , 2010, Annals of neurology.

[48]  J. Raffetto.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency , 2010 .

[49]  F. Salvi,et al.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. , 2009, Journal of vascular surgery.

[50]  Ying Zhu,et al.  [Meta-analysis on relationship between hyperhomocysteinemia and multiple sclerosis]. , 2009, Zhonghua yi xue za zhi.

[51]  John P.A. Ioannidis,et al.  Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses , 2009, Canadian Medical Association Journal.

[52]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[53]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[54]  Julian P T Higgins,et al.  Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2008, International journal of epidemiology.

[55]  S. Suissa,et al.  Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. , 2007, Archives of pediatrics & adolescent medicine.

[56]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[57]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[58]  J. Ioannidis,et al.  An exploratory test for an excess of significant findings , 2007, Clinical trials.

[59]  C. Hawkes.  Smoking is a risk factor for multiple sclerosis: a metanalysis , 2007, Multiple sclerosis.

[60]  M. Etminan,et al.  Dental amalgam and multiple sclerosis: a systematic review and meta-analysis. , 2007, Journal of public health dentistry.

[61]  P. Zamboni.  The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006 .

[62]  P. Zamboni.  The Big Idea: Iron-Dependent Inflammation in Venous Disease and Proposed Parallels in Multiple Sclerosis , 2006, Journal of the Royal Society of Medicine.

[63]  P. Bagos,et al.  Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis , 2006, Multiple sclerosis.

[64]  M. Hernán,et al.  Tetanus vaccination and risk of multiple sclerosis , 2006, Neurology.

[65]  A. Ascherio,et al.  Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.

[66]  D. Gilden.  Infectious causes of multiple sclerosis , 2005, The Lancet Neurology.

[67]  M. Hernán,et al.  Recombinant hepatitis B vaccine and the risk of multiple sclerosis , 2004, Neurology.

[68]  T. Jefferson,et al.  Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review , 2003, Journal of viral hepatitis.

[69]  D. Matchar,et al.  Immunization and MS: A summary of published evidence and recommendations , 2002, Neurology.

[70]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[71]  A. Alpérovitch,et al.  Hepatitis B Vaccination and First Central Nervous System Demyelinating Event: A Case-Control Study , 2002, Neuroepidemiology.

[72]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[73]  A. Simmons.  Herpesvirus and multiple sclerosis. , 2001, Herpes : the journal of the IHMF.

[74]  S. Chinn.  A simple method for converting an odds ratio to effect size for use in meta-analysis. , 2000, Statistics in medicine.

[75]  F. André,et al.  Is there a causal link between hepatitis B vaccination and multiple sclerosis? , 2000, Vaccine.

[76]  A. Ascherio,et al.  Epstein-Barr virus and multiple sclerosis. , 2000, Epidemiology.

[77]  A. Sadovnick,et al.  School-based hepatitis B vaccination programme and adolescent multiple sclerosis , 2000, The Lancet.

[78]  J. Ioannidis,et al.  Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.

[79]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[80]  O. Axelson,et al.  Organic solvents and multiple sclerosis: a synthesis of the current evidence. , 1996, Epidemiology.

[81]  J H Lubin,et al.  On power and sample size for studying features of the relative odds of disease. , 1990, American journal of epidemiology.

[82]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[83]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .